Big Pharma’s Hit Man
Segment # 403
A bombshell investigation by Project Veritas reveals how Johnson & Johnson (J&J), a trusted household name, allegedly uses its clout to exploit and bankrupt smaller suppliers and manufacturing partners. The 'Hitman' of Big Pharma: How Johnson & Johnson Leaves Small Companies in Ruins - YouTube
The 'Hitman' of Big Pharma: How Johnson & Johnson Leaves Small Companies in Ruins - YouTube
And Big Pharma Strikes Again - On The Flu Vaccine
A recent Cleveland Clinic study analyzing the 2024–2025 influenza vaccine suggests that vaccinated individuals were 27% more likely to contract the flu compared to their unvaccinated counterparts. The study, involving over 53,000 employees, calculated a vaccine effectiveness of -26.9%, indicating a higher risk of infection for those vaccinated. Researchers adjusted for variables such as age, sex, job type, and location, and consistently found no protective effect from the vaccine throughout the season
Key findings include:
Higher Risk Among Vaccinated: The cumulative incidence of flu infections rose more rapidly among vaccinated individuals over the 25-week study period.
Negative Vaccine Effectiveness: Adjusted analyses revealed a hazard ratio (HR) of 1.27, meaning vaccinated individuals had a statistically significant higher risk of infection (p = 0.007
Potential Causes: Researchers highlighted possible factors such as strain mismatches or immune interference but acknowledged limitations in their analysis. The study focused on the trivalent inactivated vaccine and did not assess other formulations or outcomes like hospitalizations or deaths
The findings challenge public health messaging about flu vaccine benefits and have sparked debate among experts. Critics argue that healthcare workers' higher exposure to flu and the study's observational nature could bias results. Additionally, some emphasize that flu vaccines primarily aim to reduce severe illness rather than prevent transmission entirely